CRISPR-Cas9 gene editing for patients with haemoglobinopathies.
The Lancet. Haematology, 6(9): e438 PMID 31471004 DOI 10.1016/S2352-3026(19)30169-3
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.